ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LBGJ vs TMO // EV/EBITDA & P/E VALUATION

Li Bang International Corporation (Class A) (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: LBGJ 0 — TMO 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LBGJ VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LBGJ TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 29.20% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 9.30% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield — 2.40% — TIE /fcf-yield <GO>
Operating Margin -12.20% 17.40% -29.60 TMO /operating-margins <GO>
Net Profit Margin -9.10% 15.10% -24.20 TMO /net-margins <GO>
Revenue Growth (YoY) 2.90% 3.90% -1.00 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 33.9 62.9 -29.03 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.1M $262.22B -$262.22B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LBGJ REV TMO REV LBGJ GROSS % TMO GROSS % LBGJ FCF TMO FCF
FY 2025 $11.1M $44.56B 29.2% — -$926.7K $6.29B
FY 2024 $10.8M $42.88B 25.1% — -$646.5K $7.27B
FY 2023 $14.0M $42.86B — — -$634.4K $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LBGJ // BETA —
TMO // BETA 0.94